Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remote monitoring accuracy during selexipag and riociguat treatment in pulmonary arterial hypertension
ISRCTN18119805Phase 4Active, not recruiting
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jun 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of selexipag and riociguat in pulmonary arterial hypertension (PAH), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jun 2023; status: active, not recruiting.
02
Drugs
selexipagriociguat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on ISRCTN18119805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18119805.